[Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
D000328:Adult; D000368:Aged; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D005260:Female; D006320:Hearing Tests; D006801:Humans; D007361:Intelligence Tests; D002537:Intracranial Arteriosclerosis / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008568:Memory; D008875:Middle Aged; D010919:Placebos; D011581:Psychological Tests; D011594:Psychometrics; D011600:Psychopharmacology; D011602:Psychophysiologic Disorders; D012932:Social Facilitation; D014665:Vasodilator Agents / Q000627:therapeutic use*; D015016:Yohimbine / Q000008:administration & dosage / Q000627:therapeutic use*
D010919:Placebos; D014665:Vasodilator Agents; D015016:Yohimbine
Traitement des manifestations psychiques de l'insuffisance circulatoire cérébrale chronique. Etude clinique et psychométrique.